Company / Revenue per Share
KYNTRA BIO, INC. Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$7.34
FY2025
5-year range
$0.47 / $7.34
FY2021-FY2025
Trend
+1448.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share changed +1448% YoY in FY2025, a notable deviation from the 9-year average annual change of +157%.
Based on SEC 10-K filings.
7.34 in FY2025 with a 5-year CAGR of +24.7%.
Improved from $2.50 to $7.34 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +56.9%
- 5-Year CAGR
- +24.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, revenue per share increased 1448.4% year-over-year.
- Lowest revenue per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -3.33 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.34 | +1448.4% |
| FY2024 | $0.47 | -81.0% |
| FY2023 | $2.50 | +31.6% |
| FY2022 | $1.90 | -32.3% |
| FY2021 | $2.81 | +15.5% |
| FY2020 | $2.43 | +58.4% |
| FY2019 | $1.53 | -30.9% |
| FY2018 | $2.22 | -21.8% |
| FY2017 | $2.84 | +27.9% |
| FY2016 | $2.22 | +28.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026